| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.19 | 0.2 |